Accessibility and reading comfort

Text size

Light/Dark mode

Lines vertical spacing

Trouble using our website?
Contact us

AOU Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy

In this page

How to contact the center

Full member

HCP Center

The Rare Ocular Diseases Center of the AUU Luigi Vanvitelli University of Campania offers diagnostic, rehabilitative and therapeutic courses for patients suffering from hereditary eye diseases, such as hereditary chorion-retinal dystrophies, hereditary optic diseases, keratoconus and corneal dystrophies, both in isolation and syndromic.
Patients are taken care of by a dedicated multidisciplinary team that welcomes and guides them in the treatment process, including ophthalmologists, orthoptists and nurses specialized in diagnostic and rehabilitative techniques, counselors and guidance and mobility operators to complete the qualification/rehabilitation course, as well as paediatricians, audiologists, neurologists, nephrologists for the diagnosis and treatment of syndromic forms.

To book the first diagnostic day hospital, call the Rare Eye Disease Center at the telephone number: 081 566 67 62 (every Tuesday and Thursday from 11.00 to 13.00).
To book subsequent visits on an outpatient basis (follow-up), contact the company CUP at the telephone number: 800 177 780, indicating the name of your pathology.

Picture : Falk2, via Wikimedia Commons

Contact

AOU Università degli Studi della Campania Luigi Vanvitelli, Napoli, Italy

Via Santa Maria di Costantinopoli
104, 80138 Napoli NA
Italy

Team

Pr Francesca Simonelli

Representative

Italy

Genetic Diagnostics (TWG6), National Integration (TWG9), Registries & Epidemiology (TWG7), Retinal Rare Eye Diseases (WG1)
See more

Pr Francesco Testa

Substitute

Italy

Genetic Diagnostics (TWG6), Registries & Epidemiology (TWG7), Retinal Rare Eye Diseases (WG1)
See more

Dr Valentina Di Iorio

Italy

Genetic Diagnostics (TWG6), Pediatric Ophthalmology Rare Diseases (WG3), Registries & Epidemiology (TWG7), Retinal Rare Eye Diseases (WG1)
See more

Dr Raffaella Brunetti Pierri

Italy

Genetic Diagnostics (TWG6), Registries & Epidemiology (TWG7), Retinal Rare Eye Diseases (WG1)
See more

Paolo Melillo

Italy

CPMS & Digital Medecine (TWG10)
See more

Clinical trials

NCT04855045 - Unknown

An Open-Label, Dose Escalation and Double-Masked, Randomized, Controlled Study to Evaluate the Safety and Tolerability of Sepofarsen in Pediatric Subjects G (p.Cys998X) Mutation.

Interventional
See the trial
voir la fiche
NCT04671433 - Active, Not recruiting

Phase 3 Randomized, Controlled Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Interventional
See the trial
voir la fiche

NCT04794101 - Active, Not recruiting

Phase 3 Follow-up Study of AAV5-hRKp.RPGR for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Interventional
See the trial
voir la fiche
NCT02771236 - Recruiting, Active

Clinical and Molecular Studies in Families With Inherited Eye Disease

Observational
See the trial
voir la fiche
NCT04525261 - Completed

Natural history of patients with inherited retinal diseases due to mutations in RPE65 gene

Observational
See the trial
voir la fiche
NCT03364153 - Active, Not recruiting

A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease

Interventional
See the trial
voir la fiche
NCT04435366 - Completed

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Interventional
See the trial
voir la fiche